Shen Y - Search Results

1

Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer.

Li H, Shen Y, Wu Y, Cai S, Zhu Y, Chen S, Chen X, Chen Q. Li H, et al. Among authors: shen y. J Surg Res. 2019 Nov;243:346-353. doi: 10.1016/j.jss.2019.04.083. Epub 2019 Jul 2. J Surg Res. 2019. PMID: 31277011

2

H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR.

Fang S, Shen Y, Chen B, Wu Y, Jia L, Li Y, Zhu Y, Yan Y, Li M, Chen R, Guo L, Chen X, Chen Q. Fang S, et al. Among authors: shen y. Ann Transl Med. 2018 Nov;6(22):440. doi: 10.21037/atm.2018.10.21. Ann Transl Med. 2018. PMID: 30596070 Free PMC article.

3

KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis.

Zhu Y, Shen Y, Chen R, Li H, Wu Y, Zhang F, Huang W, Guo L, Chen Q, Liu H. Zhu Y, et al. Among authors: shen y. Ann Transl Med. 2021 May;9(10):891. doi: 10.21037/atm-21-1761. Ann Transl Med. 2021. PMID: 34164525 Free PMC article.

4

Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma.

Zhong H, Wang J, Zhu Y, Shen Y. Zhong H, et al. Among authors: shen y. Front Cell Dev Biol. 2021 Sep 1;9:700607. doi: 10.3389/fcell.2021.700607. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34540825 Free PMC article.

5

Shen Y, Wang S, Wu Y. Shen Y, et al. Cells. 2022 Aug 3;11(15):2399. doi: 10.3390/cells11152399. Cells. 2022. PMID: 35954243 Free PMC article.

6

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma.

Shen Y, Li D, Liang Q, Yang M, Pan Y, Li H. Shen Y, et al. Front Immunol. 2023 Jan 17;13:1029092. doi: 10.3389/fimmu.2022.1029092. eCollection 2022. Front Immunol. 2023. PMID: 36733399 Free PMC article.

7

Causal effects of gut microbiota in the development of lung cancer and its histological subtypes: A Mendelian randomization study.

Ma Y, Deng Y, Shao T, Cui Y, Shen Y. Ma Y, et al. Among authors: shen y. Thorac Cancer. 2024 Feb;15(6):486-495. doi: 10.1111/1759-7714.15220. Epub 2024 Jan 12. Thorac Cancer. 2024. PMID: 38214421 Free PMC article.

8

Three cases of hemoglobin M disease in a family lineage: Case report and literature review.

Shen Y, Wang Y, Xue L, Li C, He L, Wu S. Shen Y, et al. Medicine (Baltimore). 2025 Jan 24;104(4):e40652. doi: 10.1097/MD.0000000000040652. Medicine (Baltimore). 2025. PMID: 39854759 Review.

9

Effectiveness of regorafenib in second-line therapy for advanced hepatocellular carcinoma: A systematic review and meta-analysis.

Shen Y, Bai Y. Shen Y, et al. Medicine (Baltimore). 2025 Jan 24;104(4):e41356. doi: 10.1097/MD.0000000000041356. Medicine (Baltimore). 2025. PMID: 39854748

10

Establishment of critical values for AMH screening with PCOS based on restricted cubic spline plots.

Wang Z, Teng X, Shen Y, Liu Y. Wang Z, et al. Among authors: shen y. Endocr Connect. 2025 Jan 1:EC-24-0522. doi: 10.1530/EC-24-0522. Online ahead of print. Endocr Connect. 2025. PMID: 39854723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,679 results

Search Page

Filters